UTILISATION DE L'HORMONE DE CROISSANCE A FAIBLE DOSE

Patent europeic · EP1265629 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1265629
Numer da la dumonda
EP01914289
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
13-03-2001
Publitgà
18-12-2002
Concedì
07-06-2006
Stritgà
31-03-2009
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 38/27 (2006.01)
//A61P 3/10 (2006.01)
Prioritad
SE 0000837 13.03.2000
Dumonda PCT
PCT/SE2001/000522 13.03.2001
Publicaziun PCT
WO2001/068127 20.09.2001
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2009

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.10.2009

  2. 31-10-2007

    Adressa midada

    Representative
    E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in +pat+ No 20 in 2007

  3. 14-07-2006

    Represchentant inscrit

    Representative
    E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich

    Published in +pat+ No 13 in 2006

  4. 15-06-2006

    Concedì

    Published in +pat+ No 11 in 2006

Partidas

Possessur

Pfizer Health AB

112 87 Stockholm, SE

Represchentant

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

Inventur

DUNGER, David B., c/o Dept. of Paediatrics

Cambridge CB2 2QQ, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.